Literature DB >> 16288226

Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activity.

X Zuo1, Y Wu, J S Morris, J B Stimmel, L M Leesnitzer, S M Fischer, S M Lippman, I Shureiqi.   

Abstract

Peroxisome proliferator-activated receptors (PPARs) are transcription factors that strongly influence molecular events in normal and cancer cells. PPAR-beta/delta (PPAR-b/d) overexpression suppresses the activity of PPAR-gamma (PPAR-g) and PPAR-alpha. This interaction has been questioned, however, by studies with synthetic ligands of PPARs in PPAR-b/d-null cells, and it is not known whether an interaction between PPAR-b/d and PPAR-g exists, especially in relation to the signaling by natural PPAR ligands. Oxidative metabolites of linoleic and arachidonic acids are natural ligands of PPARs. 13-S-hydroxyoctadecadienoic acid (13-S-HODE), the main product of 15-lipoxygenase-1 (15-LOX-1) metabolism of linoleic acid, downregulates PPAR-b/d. We tested (a) whether PPAR-b/d expression modulates PPAR-g activity in experimental models of the loss and gain of PPAR-b/d function in colon cancer cells and (b) whether 15-LOX-1 formation of 13-S-HODE influences the interaction between PPAR-b/d and PPAR-g. We found that (a) 15-LOX-1 formation of 13-S-HODE promoted PPAR-g activity, (b) PPAR-b/d expression suppressed PPAR-g activity in models of both loss and gain of PPAR-b/d function, (c) 15-LOX-1 activated PPAR-g by downregulating PPAR-b/d, and (d) 15-LOX-1 expression induced apoptosis in colon cancer cells via modulating PPAR-b/d suppression of PPAR-g. These findings elucidate a novel mechanism of the signaling by natural ligands of PPARs, which involves modulating the interaction between PPAR-b/d and PPAR-g. Oncogene (2006) 25, 1225-1241. doi:10.1038/sj.onc.1209160; published online 14 November 2005.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16288226      PMCID: PMC1432095          DOI: 10.1038/sj.onc.1209160

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  36 in total

Review 1.  Orphan nuclear receptors: shifting endocrinology into reverse.

Authors:  S A Kliewer; J M Lehmann; T M Willson
Journal:  Science       Date:  1999-04-30       Impact factor: 47.728

2.  Isolation of a somatic cell mutant resistant to the induction of apoptosis by oxidized low density lipoprotein.

Authors:  A E Rusiñol; L Yang; D Thewke; S R Panini; M F Kramer; M S Sinensky
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

3.  Differential localization by in situ hybridization of distinct keratin mRNA species during intestinal epithelial cell development and differentiation.

Authors:  D Calnek; A Quaroni
Journal:  Differentiation       Date:  1993-06       Impact factor: 3.880

4.  Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma.

Authors:  L Nagy; P Tontonoz; J G Alvarez; H Chen; R M Evans
Journal:  Cell       Date:  1998-04-17       Impact factor: 41.582

5.  A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis.

Authors:  M Gurnell; J M Wentworth; M Agostini; M Adams; T N Collingwood; C Provenzano; P O Browne; O Rajanayagam; T P Burris; J W Schwabe; M A Lazar; V K Chatterjee
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

6.  Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1.

Authors:  B Jiménez; O V Volpert; S E Crawford; M Febbraio; R L Silverstein; N Bouck
Journal:  Nat Med       Date:  2000-01       Impact factor: 53.440

7.  Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers.

Authors:  I Shureiqi; K J Wojno; J A Poore; R G Reddy; M J Moussalli; S A Spindler; J K Greenson; D Normolle; A A Hasan; T S Lawrence; D E Brenner
Journal:  Carcinogenesis       Date:  1999-10       Impact factor: 4.944

8.  15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells.

Authors:  I Shureiqi; D Chen; J J Lee; P Yang; R A Newman; D E Brenner; R Lotan; S M Fischer; S M Lippman
Journal:  J Natl Cancer Inst       Date:  2000-07-19       Impact factor: 13.506

9.  Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase.

Authors:  J T Huang; J S Welch; M Ricote; C J Binder; T M Willson; C Kelly; J L Witztum; C D Funk; D Conrad; C K Glass
Journal:  Nature       Date:  1999-07-22       Impact factor: 49.962

10.  PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs.

Authors:  T C He; T A Chan; B Vogelstein; K W Kinzler
Journal:  Cell       Date:  1999-10-29       Impact factor: 41.582

View more
  47 in total

Review 1.  15-Lipoxygenase-1 as a tumor suppressor gene in colon cancer: is the verdict in?

Authors:  Sun Il Lee; Xiangsheng Zuo; Imad Shureiqi
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

2.  Honokiol inhibits gastric tumourigenesis by activation of 15-lipoxygenase-1 and consequent inhibition of peroxisome proliferator-activated receptor-gamma and COX-2-dependent signals.

Authors:  Shing Hwa Liu; Chin Chang Shen; Yu Chiao Yi; Jaw Ji Tsai; Chih Chien Wang; Ju Ting Chueh; Keh Liang Lin; Tso Ching Lee; Hung Chuan Pan; Meei Ling Sheu
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 3.  The role of nuclear receptors in regulation of Th17/Treg biology and its implications for diseases.

Authors:  Benjamin V Park; Fan Pan
Journal:  Cell Mol Immunol       Date:  2015-09       Impact factor: 11.530

Review 4.  ALOX15 as a suppressor of inflammation and cancer: Lost in the link.

Authors:  Rui Tian; Xiangsheng Zuo; Jonathan Jaoude; Fei Mao; Jennifer Colby; Imad Shureiqi
Journal:  Prostaglandins Other Lipid Mediat       Date:  2017-01-13       Impact factor: 3.072

Review 5.  Cyclooxygenases and lipoxygenases in cancer.

Authors:  Claus Schneider; Ambra Pozzi
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

6.  Therapeutic molecular targeting of 15-lipoxygenase-1 in colon cancer.

Authors:  Yuanqing Wu; Bingliang Fang; Xiulan Q Yang; Li Wang; Dongning Chen; Victor Krasnykh; Bing Z Carter; Jeffrey S Morris; Imad Shureiqi
Journal:  Mol Ther       Date:  2008-03-18       Impact factor: 11.454

7.  Effect of ω-3 and ω-9 fatty acid rich oils on lipoxygenases and cyclooxygenases enzymes and on the growth of a mammary adenocarcinoma model.

Authors:  Andrea Comba; Damian M Maestri; María A Berra; Carolina Paola Garcia; Undurti N Das; Aldo R Eynard; María E Pasqualini
Journal:  Lipids Health Dis       Date:  2010-10-08       Impact factor: 3.876

8.  15-lipoxygenase-1 activates tumor suppressor p53 independent of enzymatic activity.

Authors:  Hong Zhu; Wayne Glasgow; Margaret D George; Kali Chrysovergis; Kenneth Olden; John D Roberts; Thomas Eling
Journal:  Int J Cancer       Date:  2008-12-15       Impact factor: 7.396

Review 9.  Targeting peroxisome proliferator-activated receptor-β/δ in colon cancer: how to aim?

Authors:  Min Xu; Xiangsheng Zuo; Imad Shureiqi
Journal:  Biochem Pharmacol       Date:  2012-10-04       Impact factor: 5.858

10.  Rat Urinary Bladder Carcinogenesis by Dual-Acting PPARalpha + gamma Agonists.

Authors:  Martin B Oleksiewicz; Jennifer Southgate; Lars Iversen; Frederikke L Egerod
Journal:  PPAR Res       Date:  2009-01-28       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.